Drug Shortage Report for LEUCOVORIN CALCIUM INJECTION USP
Report ID | 14489 |
Drug Identification Number | 02183005 |
Brand name | LEUCOVORIN CALCIUM INJECTION USP |
Common or Proper name | Levoleucovorin Calcium |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | LEUCOVORIN |
Strength(s) | 10MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 1x 5mL VIAL / AMPOULE |
ATC code | V03AF |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-07-10 |
Actual start date | |
Estimated end date | 2017-10-18 |
Actual end date | 2017-10-17 |
Shortage status | Resolved |
Updated date | 2017-10-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2017-10-18 | French | Compare |
v10 | 2017-10-18 | English | Compare |
v9 | 2017-10-12 | French | Compare |
v8 | 2017-10-12 | English | Compare |
v7 | 2017-07-14 | French | Compare |
v6 | 2017-07-14 | English | Compare |
v5 | 2017-07-11 | English | Compare |
v4 | 2017-07-04 | French | Compare |
v3 | 2017-07-04 | English | Compare |
v2 | 2017-07-03 | French | Compare |
v1 | 2017-07-03 | English | Compare |
Showing 1 to 11 of 11